Anti-CCP IgA
Anti-CCP IgA measures the levels of Immunoglobulin A antibodies against cyclic citrullinated peptides, which are often elevated in rheumatoid arthritis.
Anti-CCP IgA is a diagnostic biomarker for rheumatoid arthritis.
Key facts at a glance
- Units
- U/mL
- Clinical utility
- diagnostic
- Result kind
- quantitative
- FDA-cleared
- Roche Anti-CCP IgA, Inova Anti-CCP IgA
Anti-CCP IgA is an antibody test that detects Immunoglobulin A antibodies targeting cyclic citrullinated peptides (CCP). These antibodies are highly specific for rheumatoid arthritis (RA) and can be detected in the early stages of the disease.
The presence of Anti-CCP IgA antibodies is strongly associated with more severe joint damage and a poorer prognosis in RA patients. This makes it a valuable tool for early diagnosis and intervention.
Measuring Anti-CCP IgA levels can help differentiate RA from other inflammatory joint diseases, guiding appropriate treatment strategies and improving patient outcomes.
Frequently asked questions
What is the normal range for Anti-CCP IgA?
How is an elevated Anti-CCP IgA level treated?
Sources
- 1
- 2
Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy